Probiotic Therapy of Gastrointestinal Symptoms During COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled, Remote Study
Patients with mild COVID-19 disease in home quarantine exhibited respiratory symptoms, a reduced gastrointestinal quality of life, and changes in the fecal microbiome and metabolome.
Authors
- Vanessa Stadlbauer (ORCID: https://orcid.org/0000-0001-5508-8271)
- Hansjörg Habisch (ORCID: https://orcid.org/0000-0001-5537-506X)
- Angela Horvath (ORCID: https://orcid.org/0000-0001-7279-0628)
- Nicole Feldbacher
- Tobias Madl (ORCID: https://orcid.org/0000-0002-9725-5231)
- Kristina Žukauskaitė (ORCID: https://orcid.org/0000-0002-8707-6598)
- R. De Haller
Institutions
- Vilnius University (LT)
- Medical University of Graz (AT)
- BioTechMed-Graz (AT)
- Center For Biomarker Research In Medicine (AT)
Publication Details
- Journal
- Nutrients
- Published
- 2024-11-20
- DOI
- https://doi.org/10.3390/nu16223970
- Citations
- 7
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 1.64
Funders
- Austrian Science Fund
- Österreichische Forschungsförderungsgesellschaft
- Karl-Franzens-Universität Graz
- Medizinische Universität Graz
- BioTechMed-Graz